Day: June 5, 2025

Bpifrance Investissement steps down from the Elis Supervisory Board Saint-Cloud, 5 June 2025 – Bpifrance Investissement (management company of Lac 1), a member of the Supervisory Board of Elis since January 9, 2023, has informed the company of its resignation from the Supervisory Board, effective June 5, 2025. In this role, Bpifrance Investissement was represented by Paul-Philippe Bernier and also served on the Nominations, Compensation and Governance Committee. This decision follows the sale of 6,900,000 Elis shares announced on June 3, 2025, and is in accordance with the governance agreement between Bpifrance Investissement and Elis. Thierry Morin, Chairman of the Supervisory Board, has acknowledged this resignation and extends his thanks to Bpifrance Investissement and Paul-Philippe Bernier for their valuable contributions to the work...

5 June 2025 – DNO ASA, the Norwegian oil and gas operator, today completed a private placement of USD 400 million of subordinated hybrid bonds with a coupon rate of 10.75 percent. The hybrid bonds will have the first call at 100 percent of nominal value after 5.5 years, with coupon step-up after six years and maturity in 2085. The bond placement met strong investor demand across US, Nordic and international markets and was significantly oversubscribed. “This first hybrid bond issue capitalizes on our 24-year flawless record in the bond market,” said DNO’s Executive Chairman Bijan Mossavar-Rahmani. “Given its features, including treatment as equity not debt on DNO’s balance sheet, a hybrid bond fits well with our financing structure following closing of the Sval Energi Group AS acquisition later this month,” he added.   Settlement is expected...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) — ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”): Further to the press release issued on May 6, 2025, ExGen was advised that Earl Hope currently holds 60,500 common shares of ExGen, which were purchased through a brokerage account prior to the execution of the investor relations agreement. Earl Hope may buy or sell common shares of ExGen in the future, in compliance with securities laws, depending on market conditions. ABOUT EXGEN RESOURCES INC. ExGen is a project accelerator that seeks to fund exploration and development of our projects through joint ventures and partnership agreements. This approach significantly reduces the technical and financial...

Total number of shares and voting rights in the share capital as of April 30 , 2025 (Articles L. 233-8 (II) of the French Commercial Code and 223-16 of the General Regulations of the French Financial Markets Authority) Date  Total number of shares in the capital   Number of theoretical voting rights  Number of exercisable voting rights 04/30/2025  131 318 716 220 414 222 219 980 934Next on the agenda: Q2 2025 Turnover, July 23, 2025 (after market close)About Voltalia (www.voltalia.com)Voltalia is an international player in the renewable energy sector. The Group produces and sells electricity generated from wind, solar, hydraulic, biomass and storage facilities that it owns and operates. Voltalia has generating capacity in operation and under construction of more than 3.3 GW and a portfolio...

Disclosure Of Trading In Own SharesFor May 2025 Clichy, France – June 05, 2025 In compliance with general regulation on share buy-backs, Société BIC declares below the transactions made on its own shares for May 2025:No transactions for May 2025.ContactsBrice ParisVP Investor Relations +33 6 42 87 54 73brice.paris@bicworld.com   Investor Relationsinvestors.info@bicworld.com       Bethridge ToovellVP Global Communications+1 917 821 4249bethridge.toovell@bicworld.com   Isabelle de Segonzac Image 7, Press Relations contact+33 6 89 87 61 39isegonzac@image7.fr  Agenda All dates to be confirmedFirst Half 2025 Results July 30, 2025Third Quarter 2025 Net Sales October 28, 2025About BIC A global leader in stationery, lighters, and shavers, BIC brings...

IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full dose Six-month data confirm full dose selection for pivotal Phase 3 trialSaint-Herblain (France), June 5, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced positive six-month antibody persistence and safety data for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its single-shot chikungunya vaccine, IXCHIQ®, in 304 children. Partially funded by the Coalition for Epidemic Preparedness Innovations (CEPI), with support from the European Union, the trial is intended to support a pivotal Phase 3 study in children,...